This course
bridges scientific advancement and clinical practice, equipping healthcare
professionals to transform care for patients with nano-rare diseases. This
course provides participants with foundational knowledge of RNA genetics,
antisense oligonucleotide (ASO) mechanisms, and clinical applications, while
training healthcare professionals to identify appropriate candidates for ASO
therapy and manage patient care effectively. It also fosters a global network
of trained professionals to advance GINaRT’s mission of equitable access to ASO
therapies for nano-rare diseases.
This course provides participants with
foundational knowledge of RNA genetics, antisense oligonucleotide (ASO)
mechanisms, and clinical applications, while training healthcare professionals
to identify appropriate candidates for ASO therapy and manage patient care
effectively. It also fosters a global network of trained professionals to
advance GINaRT’s mission of equitable access to ASO therapies for nano-rare
diseases.
